The oral reversibly-binding antiplatelet agent, Ticagrelor, acts as an antagonist at the P2Y-like receptor GPR17

The oral reversibly-binding antiplatelet agent, Ticagrelor, acts as an antagonist at the P2Y-like receptor GPR17 / C. Martini, S. Daniele, M.L. Trincavelli, D. Lecca, A. Panighini, M.P. Abbracchio. - In: PURINERGIC SIGNALLING. - ISSN 1573-9538. - 6:Suppl. 1(2010), pp. s162-s162. ((Intervento presentato al convegno Purines 2010 – Adenine Nucleosides and Nucleotides in Biomedicine tenutosi a Tarragona nel 2010 [10.1007/s11302-010-9187-6].